This inventor holds 1 USPTO granted patent. Top assignee: Osypka Ag. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: Astrid Virnich: Innovator in Cardiac Technology
Introduction
Astrid Virnich is a notable inventor based in Rheinfelden, Germany. She has made significant contributions to the field of cardiac technology, particularly with her innovative designs for external pacemakers. Her work is characterized by a commitment to improving patient care and enhancing the functionality of medical devices.
Latest Patents
Astrid holds a patent for an external pacemaker with an electrode that is temporarily connectable to the heart. This device features an active region at the distal end that makes contact with heart tissue, while the proximal end includes a contact plug. The electrode is designed for the transmission of stimulation, defibrillation, and/or cardioversion pulses. The contact plug has first and second contact regions, which correspond to a pacemaker plug socket that matches the contact plug with two mating contacts. This innovative design ensures that defibrillation and/or cardioversion pulses are only transmitted to suitable electrodes, enhancing the safety and effectiveness of the device.
Career Highlights
Astrid Virnich is currently employed at Osypka AG, where she continues to develop cutting-edge medical technologies. Her work has been instrumental in advancing the capabilities of external pacemakers, making them safer and more efficient for patients in need of cardiac support.
Collaborations
Astrid collaborates with talented colleagues, including Maik Grafe and Thorsten Gottsche. Together, they work towards innovative solutions in the medical device industry, contributing to advancements that benefit patients and healthcare providers alike.
Conclusion
Astrid Virnich's contributions to cardiac technology exemplify her dedication to innovation and patient care. Her patent for an external pacemaker highlights her role as a leading inventor in the medical field. Through her work at Osypka AG and collaborations with her colleagues, she continues to make a significant impact on the future of medical technology.